Certified by Founder Lodge
F2G
United Kingdom - Manchester, England
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
1998
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections. F2G has discovered and deve
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 13 ,2024 | Unknown | $100,000,000 |
Novo Holdings
Advent Life Sciences
Forbion
AMR Action Fund
Merifin Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
